Exos Asset Management’s Avanos Medical AVNS Stock Holding History

Exos Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,443	Closed	-$52K	–	478
2021 Q2	$52K	Buy	+1,443	New	+$59.7K	0.03%	553

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Exos Asset Management's AVNS Position: Q3 2021 in Review

Exos Asset Management sold out of Avanos Medical (AVNS) in Q3 2021, closing a stake of 1,443 shares — an estimated $52K sold.

Exos Asset Management first reported a position in AVNS in Q2 2021 and held it in 1 quarter. The position peaked at $52K in Q2 2021. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2021.

Exos Asset Management reported no remaining Avanos Medical position as of Q3 2021 after selling out during the quarter.
Exos Asset Management sold 1,443 Avanos Medical shares in Q3 2021, an estimated $52K.
Exos Asset Management first reported a position in Avanos Medical in Q2 2021 and held it in 1 quarter.
Exos Asset Management's Avanos Medical position peaked at $52K in Q2 2021.
274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.